Mu YF - Search Results

1

The clinical impact of ICOS signal in colorectal cancer patients.

Zhang Y, Luo Y, Qin SL, Mu YF, Qi Y, Yu MH, Zhong M. Zhang Y, et al. Among authors: mu yf. Oncoimmunology. 2016 Mar 10;5(5):e1141857. doi: 10.1080/2162402X.2016.1141857. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467961 Free PMC article.

2

Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients.

Wang ZS, Cong ZJ, Luo Y, Mu YF, Qin SL, Zhong M, Chen JJ. Wang ZS, et al. Among authors: mu yf. Int J Clin Exp Pathol. 2014 Oct 15;7(11):8077-81. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25550854 Free PMC article.

3

[Impact of lysosome-associated protein transmembrane-4 beta on proliferation and invasion of colorectal cancer].

Luo Y, Bian Z, Ye G, Yu M, Wang Z, Qin S, Mu Y, Zhong M. Luo Y, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Jun;18(6):606-10. Zhonghua Wei Chang Wai Ke Za Zhi. 2015. PMID: 26108779 Chinese.

4

Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.

Luo Y, Qin SL, Mu YF, Wang ZS, Zhong M, Bian ZQ. Luo Y, et al. Among authors: mu yf. Biomed Pharmacother. 2015 Jul;73:135-9. doi: 10.1016/j.biopha.2015.06.007. Epub 2015 Jul 9. Biomed Pharmacother. 2015. PMID: 26211594

5

Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.

Yu MH, Luo Y, Qin SL, Wang ZS, Mu YF, Zhong M. Yu MH, et al. Among authors: mu yf. Am J Cancer Res. 2015 Aug 15;5(9):2708-18. eCollection 2015. Am J Cancer Res. 2015. PMID: 26609478 Free PMC article.

6

Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.

Luo Y, Qin SL, Yu MH, Mu YF, Wang ZS, Zhong M. Luo Y, et al. Among authors: mu yf. Biomed Pharmacother. 2015 Dec;76:147-52. doi: 10.1016/j.biopha.2015.10.012. Epub 2015 Nov 18. Biomed Pharmacother. 2015. PMID: 26653562

7

ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells.

Luo Y, Ye GY, Qin SL, Yu MH, Mu YF, Zhong M. Luo Y, et al. Among authors: mu yf. Gastroenterol Res Pract. 2015;2015:936564. doi: 10.1155/2015/936564. Epub 2015 Nov 30. Gastroenterol Res Pract. 2015. PMID: 26697062 Free PMC article.

8

High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.

Luo Y, Ye GY, Qin SL, Mu YF, Zhang L, Qi Y, Qiu YE, Yu MH, Zhong M. Luo Y, et al. Among authors: mu yf. Int J Biochem Cell Biol. 2016 Jun;75:53-62. doi: 10.1016/j.biocel.2016.03.017. Epub 2016 Mar 29. Int J Biochem Cell Biol. 2016. PMID: 27046094

9

MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.

Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL, Yu MH, Qin J. Wang ZS, et al. Among authors: mu yf. Oncotarget. 2016 Jul 12;7(28):44266-44276. doi: 10.18632/oncotarget.10023. Oncotarget. 2016. PMID: 27329595 Free PMC article.

10

Odontogenic ameloblast-associated protein (ODAM) inhibits human colorectal cancer growth by promoting PTEN elevation and inactivating PI3K/AKT signaling.

Yu M, Mu Y, Qi Y, Qin S, Qiu Y, Cui R, Zhong M. Yu M, et al. Biomed Pharmacother. 2016 Dec;84:601-607. doi: 10.1016/j.biopha.2016.09.076. Epub 2016 Sep 29. Biomed Pharmacother. 2016. PMID: 27694004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters